Skip to main content

The Start of a New Era for Stroke Treatment: Mechanical Thrombectomy Devices

Buy Article:

$68.00 + tax (Refund Policy)

Stroke is a major cause of mortality in the U.K. accounting for 53,000 deaths every year. There are few options for the treatment of acute ischemic stroke and recombinant tissue plasminogen activator (rt-PA) remains the only approved and currently available thrombolytic therapy given within the first 3 hours after symptom onset. Mechanical thrombectomy is a promising new treatment modality for patients who are ineligible for or failing intravenous rt-PA, or presenting beyond the narrow 3-hour therapeutic window, and emerged with the development of the Merci retrieval system. A number of devices are now available and can be divided into two major subgroups according to their mode of action. Those using a proximal approach such as aspiration devices (Penumbra system) act by applying a vacuum to the proximal aspect of the thrombus whereas distal devices (Merci retrieval system, Phenox clot retriever, and Catch device) such as coil-like and basket-like devices are advanced through the thrombus thereby contacting its distal aspect. In this review, we discuss the procedure and technique, as well as evidence associated with four mechanical retrieval systems currently available: the Merci Retriever System, the Penumbra system, the Catch device, and the Phenox clot retriever. We also consider potential novel approaches for stroke treatment including waterjet thrombectomy and laser recanalization.





Keywords: Clot removal device; laser recanalization; mechanical thrombectomy; recombinant tissue plasminogen activator (rt-PA); stroke; waterjet thrombectomy

Document Type: Research Article

Publication date: 01 February 2011

More about this publication?
  • Current Neurovascular Research (CNR) provides a cross platform for the publication of scientifically rigorous research that addresses disease mechanisms of both neuronal and vascular origins in neuroscience. The journal serves as an international forum for the publication of novel and pioneering original work as well as timely neuroscience research reviews in the disciplines of cell developmental disorders, plasticity, and degeneration that bridge the gap between basic science research and clinical discovery. CNR emphasizes the elucidation of disease mechanisms, both cellular and molecular, which can impact the development of unique therapeutic strategies for neuronal and vascular disorders.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content